Trump Orders White House Board to Gain Approval Power Over NIH's $48B Grant Budget
Trump has directed the White House to draft a plan giving a new board authority to approve NIH grant funding.
The White House is drafting a plan that would give a new White House-level board the power to approve grants issued by the National Institutes of Health, the federal government's primary biomedical research agency. The move would represent one of the most significant structural shifts in how NIH funding decisions are made, inserting direct executive oversight into a process that has historically been governed by peer review among scientists. At stake is NIH's roughly $48 billion annual budget, the bulk of which flows out as research grants to universities, hospitals, and laboratories across the country. Under the current system, panels of independent scientific experts evaluate grant applications and make funding recommendations with limited political involvement. The proposed board would place White House officials in a position to approve or presumably reject those funding decisions. The directive to draft this plan comes from President Trump, though the specific composition of the proposed board, the criteria it would use to evaluate grants, and the timeline for implementation have not been detailed in available reporting. The plan is described as still being developed inside the White House rather than finalized or enacted. NIH is part of the Department of Health and Human Services and funds research into diseases ranging from cancer to infectious illness. Its grants support tens of thousands of researchers nationwide, and the agency's funding decisions have long been considered insulated from direct political direction as a matter of scientific integrity and tradition. The proposal arrives amid a broader effort by the Trump administration to assert greater executive control over federal agencies and their spending, including earlier moves to freeze or scrutinize NIH grants on various grounds.
Why it matters
NIH grants are the financial backbone of much of American biomedical research, and shifting approval authority to a White House board could redirect billions of dollars based on political rather than scientific criteria. Researchers, universities, and public health institutions that depend on NIH funding would face a fundamentally different and less predictable funding environment.
What's next
The White House plan is still being drafted, so the next milestone to watch is when a formal proposal is released detailing the board's composition, authority, and implementation timeline.
Key facts
- Trump has ordered the White House to develop a plan for a new board with authority to approve NIH grants.
- NIH's annual budget is approximately $48 billion, the majority of which is distributed as research grants.
- NIH is the United States' leading federal biomedical research agency, housed within the Department of Health and Human Services.
- Under the current system, independent panels of scientific peers evaluate and recommend grant awards with limited political involvement.
- The plan is still in the drafting stage inside the White House and has not been formally implemented.
- The move is part of a broader Trump administration effort to increase executive branch control over federal agency operations and spending.
Bias & framing notes
All seven sources carry identical reporting text — a single wire-style dispatch — so there is no independent corroboration and no dissenting framing or additional detail present. The story lacks named sources, official documents, or quotes from either administration officials or critics, making it impossible to assess the plan's specifics or surface competing perspectives. The score reflects the absence of independent sourcing, not any apparent political bias.
NewsClear — neutral news & congressional tracking · Bill of the Week